BACAX | VENAX | BACAX / VENAX | |
Total Expense Ratio | 1.32 | 0.09 | 1,467% |
Annual Report Gross Expense Ratio | 1.36 | 0.09 | 1,511% |
Fund Existence | 21 years | 21 years | - |
Gain YTD | 8.557 | 4.789 | 179% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 273M | 8.78B | 3% |
Annual Yield % from dividends | 2.21 | 3.07 | 72% |
Returns for 1 year | 2.16 | -0.16 | -1,375% |
Returns for 3 years | 22.43 | 11.38 | 197% |
Returns for 5 years | 152.37 | 159.90 | 95% |
Returns for 10 years | 76.01 | 41.16 | 185% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FCEF | 22.81 | 0.03 | +0.13% |
First Trust Income Opportunity ETF | |||
MNTL | 23.80 | N/A | N/A |
Tema ETF Trust Tema Neuroscience and Mental Health ETF | |||
TXUG | 25.75 | N/A | N/A |
Thornburg International Growth ETF | |||
RWK | 125.80 | -0.06 | -0.05% |
Invesco S&P MidCap 400 Revenue ETF | |||
THNQ | 59.25 | -0.35 | -0.59% |
Robo Global® Artificial Intelligence ETF |